位置:成果数据库 > 期刊 > 期刊详情页
结核分枝杆菌痰培养及耐利福平药敏试验分析
  • ISSN号:1008-6706
  • 期刊名称:《中国基层医药》
  • 时间:0
  • 分类:R378.911[医药卫生—病原生物学;医药卫生—基础医学]
  • 作者机构:[1]淮南市疾病预防控制中心结核门诊,安徽省淮南232001
  • 相关基金:基金项目:安徽省淮南市科技计划项目(2006农20)
中文摘要:

目的分析影响结核分枝杆菌痰培养及耐利福平药敏试验的结果及相关因素。方法对227例痰涂片阳性患者进行痰培养及耐利福平的药敏试验。结果227例中痰培养阳性220例(96.9%),涂阳培阴2例(O.9%),污染5例(2.2%)。耐利福平药敏试验中,新患者耐药比率为10.4%,初治失败者为37.5%,复治者为28.9%。结论结核分枝杆菌在培养、药敏过程中要严格按照操作步骤进行,初治失败患者和复治患者耐利福平比率远高于新患者。

英文摘要:

Objective To analyze influence mycobacterium tuberculosis sputum culture and heat-proof rifabutin antimicrobial susceptibility test results and related factors. Methods To the centers for disease control and prevention of Huainan tuberculosis clinic into the program to treat 227 sputum smear-positive patients in the sputum culture and heat-proof rifabutin of antimicrobial susceptibility test. Results Among 227 patients sputum culture positive 220 cases, accounting for 96. 9%, sputum culture-negative 2 cases, accounting for 0. 9%, pollution, 5 cases of 2. 2%. Resistance rifabutin antimicrobial susceptibility test, a new patient resistance ratio for 10.4%, early cure loser for 37. 5%, concomitant person for 28.9%. Conclusion The mycobacterium tuberculosis in the process of cultivation should be strictly according to the requirements of collecting, processing, specimen vaccination, preservation and observation. Early cure failure patients and treat patients resistant rifabutin rate was far higher than new patients, the patients with irregular or unreasonable chemotherapy were concerned.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国基层医药》
  • 主管单位:中华人民共和国卫生和计划生育委员会
  • 主办单位:中华医学会 安徽医科大学
  • 主编:
  • 地址:中国安徽淮南市洞山中路16号
  • 邮编:232001
  • 邮箱:cjpmpvip@163.com
  • 电话:0554-6665318 6664827
  • 国际标准刊号:ISSN:1008-6706
  • 国内统一刊号:ISSN:34-1190/R
  • 邮发代号:82-948
  • 获奖情况:
  • 国内外数据库收录:
  • 美国化学文摘(网络版)
  • 被引量:47111